InnoCare Pharma Limited (SHA:688428)

InnoCare Pharma Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	26,582	11,483	11,902	20,745	17,185	14,633
Market Cap Growth	111.70%	-3.52%	-42.63%	20.72%	17.44%	-
Enterprise Value	20,840	5,745	4,237	12,643	12,331	11,649
Last Close Price	25.34	12.28	11.50	14.11	-	-
PS Ratio	18.63	11.38	16.11	33.17	16.48	10727.94
PB Ratio	3.98	1.70	1.66	2.71	3.04	4.63
P/TBV Ratio	4.15	1.78	1.73	2.75	3.09	4.78
P/OCF Ratio	-	-	-	-	102.87	-
EV/Sales Ratio	14.63	5.69	5.74	20.22	11.82	8540.54
Debt / Equity Ratio	0.19	0.23	0.23	0.20	0.23	0.37
Asset Turnover	0.15	0.10	0.07	0.07	0.18	0
Inventory Turnover	1.51	1.29	1.39	3.81	11.13	-
Quick Ratio	6.14	7.01	4.13	4.43	19.29	38.75
Current Ratio	6.54	7.45	4.21	4.48	19.49	39.18
Return on Equity (ROE)	-3.55%	-6.50%	-8.71%	-13.44%	-1.51%	-368.36%
Return on Assets (ROA)	-2.18%	-3.52%	-4.15%	-5.48%	-1.91%	-9.77%
Return on Capital (ROIC)	-2.54%	-3.97%	-4.66%	-6.02%	-2.02%	-10.37%
Return on Capital Employed (ROCE)	-4.00%	-6.50%	-8.60%	-9.40%	-2.60%	-12.60%
Earnings Yield	-0.86%	-3.84%	-5.30%	-4.27%	-0.38%	-2.67%
FCF Yield	-0.61%	-3.86%	-7.73%	-3.82%	-0.02%	-2.89%
Buyback Yield / Dilution	5.87%	0.67%	-15.31%	-8.29%	-41.21%	-321.19%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.